RaySearch Laboratories AB (publ) (STO:RAY.B)
183.40
-1.60 (-0.86%)
At close: Mar 27, 2026
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 6.29 billion as of March 27, 2026. Its market cap has decreased by -20.43% in one year.
Market Cap
6.29B
Enterprise Value
6.27B
Revenue
1.34B
Ranking
n/a
PE Ratio
27.58
Stock Price
183.40
Market Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 6.29B, an increase of 3,222.60%. That is a compound annual growth rate of 16.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.29B | -19.56% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 131.42B |
| Getinge AB | 50.33B |
| Sectra AB | 43.16B |
| BioArctic AB | 28.32B |
| Ambea AB | 10.56B |
| Synsam AB | 9.23B |
| Dynavox Group AB | 8.80B |
| MedCap AB | 7.00B |